Jiashuo WU - Search Results

1

DeepCCDS: Interpretable Deep Learning Framework for Predicting Cancer Cell Drug Sensitivity through Characterizing Cancer Driver Signals.

Wu J, Lai J, Zhao X, Wang Z, Zhang Y, Wang L, Su Y, He Y, Li S, Jiang Y, Han J. Wu J, et al. Adv Sci (Weinh). 2025 Jun;12(23):e2416958. doi: 10.1002/advs.202416958. Epub 2025 May 21. Adv Sci (Weinh). 2025. PMID: 40397390 Free PMC article.

2

ProgModule: A novel computational framework to identify mutation driver modules for predicting cancer prognosis and immunotherapy response.

Li X, Pan B, Zhao X, Su Y, Lai J, Li S, He Y, Wu J, Han J. Li X, et al. Among authors: wu j. J Transl Med. 2025 May 8;23(1):518. doi: 10.1186/s12967-025-06497-0. J Transl Med. 2025. PMID: 40340863 Free PMC article.

3

Knowledge-Based Artificial Intelligence System for Drug Prioritization.

Su Y, Wu J, Zhao X, Hao Y, Wang Z, Zhang Y, Tang Y, Pan B, Wang G, Kong Q, Han J. Su Y, et al. Among authors: wu j. J Chem Inf Model. 2025 Apr 14;65(7):3827-3840. doi: 10.1021/acs.jcim.5c00027. Epub 2025 Mar 26. J Chem Inf Model. 2025. PMID: 40138572

4

CITMIC: Comprehensive Estimation of Cell Infiltration in Tumor Microenvironment based on Individualized Intercellular Crosstalk.

Zhao X, Wu J, Lai J, Pan B, Ji M, Li X, He Y, Han J. Zhao X, et al. Among authors: wu j. Adv Sci (Weinh). 2025 Jan;12(1):e2408007. doi: 10.1002/advs.202408007. Epub 2024 Nov 5. Adv Sci (Weinh). 2025. PMID: 39498855 Free PMC article.

5

IDMIR: identification of dysregulated miRNAs associated with disease based on a miRNA-miRNA interaction network constructed through gene expression data.

Wu J, Zhao X, He Y, Pan B, Lai J, Ji M, Li S, Huang J, Han J. Wu J, et al. Brief Bioinform. 2024 May 23;25(4):bbae258. doi: 10.1093/bib/bbae258. Brief Bioinform. 2024. PMID: 38801703 Free PMC article.

6

27-Hydroxycholesterol/liver X receptor/apolipoprotein E mediates zearalenone-induced intestinal immunosuppression: A key target potentially linking zearalenone and cancer.

Ruan H, Zhang J, Wang Y, Huang Y, Wu J, He C, Ke T, Luo J, Yang M. Ruan H, et al. Among authors: wu j. J Pharm Anal. 2024 Mar;14(3):371-388. doi: 10.1016/j.jpha.2023.08.002. Epub 2023 Aug 9. J Pharm Anal. 2024. PMID: 38618245 Free PMC article.

7

DrugSim2DR: systematic prediction of drug functional similarities in the context of specific disease for drug repurposing.

Wu J, Li J, He Y, Huang J, Zhao X, Pan B, Wang Y, Cheng L, Han J. Wu J, et al. Gigascience. 2022 Dec 28;12:giad104. doi: 10.1093/gigascience/giad104. Epub 2023 Dec 19. Gigascience. 2022. PMID: 38116825 Free PMC article.

8

PathwayTMB: A pathway-based tumor mutational burden analysis method for predicting the clinical outcome of cancer immunotherapy.

Li X, He Y, Jiang Y, Pan B, Wu J, Zhao X, Huang J, Wang Q, Cheng L, Han J. Li X, et al. Among authors: wu j. Mol Ther Nucleic Acids. 2023 Sep 7;34:102026. doi: 10.1016/j.omtn.2023.09.003. eCollection 2023 Dec 12. Mol Ther Nucleic Acids. 2023. PMID: 37744173 Free PMC article.

9

Zearalenone Exposure Disrupts STAT-ISG15 in Rat Colon: A Potential Linkage between Zearalenone and Inflammatory Bowel Disease.

Ruan H, Wu J, Zhang F, Jin Z, Tian J, Xia J, Luo J, Yang M. Ruan H, et al. Among authors: wu j. Toxins (Basel). 2023 Jun 9;15(6):392. doi: 10.3390/toxins15060392. Toxins (Basel). 2023. PMID: 37368693 Free PMC article.

10

DTSEA: A network-based drug target set enrichment analysis method for drug repurposing against COVID-19.

Su Y, Wu J, Li X, Li J, Zhao X, Pan B, Huang J, Kong Q, Han J. Su Y, et al. Among authors: wu j. Comput Biol Med. 2023 Jun;159:106969. doi: 10.1016/j.compbiomed.2023.106969. Epub 2023 Apr 21. Comput Biol Med. 2023. PMID: 37105108 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters